The PERK-dependent UPR signaling pathway is strictly correlated with cancer invasion and metastasis on the molecular level and therefore it is being thoroughly investigated worldwide for development of a novel anti-cancer treatment strategy [137,203]. The gene discussed is EIF2AK3; the disease is cancer.